Investorideas.com
Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas is on Medium  Investorideas RSS 


Investorideas podcasts on iTunes, Google Play Music and iHeart.com

 


Investor Research for Marijuana Stocks

Marijuana / Hemp Stocks

At Cannabisinvestorideas.com and Investorideas.com

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news


Featured marijuana stocks

CannaSOS is a comprehensive social network and advertising platform geared towards worldwide cannabis industry. CannaSOS is divided into multiple sections: Strain Database, Pulse, Advice, Business, Store, News, Social, all developed primarily to generate leads for businesses.

Since opening the doors to the public in January of 2014, CannaSOS acquired over 315,000+ registered members, 970+ active business pages, 4,900+ marijuana strain database, 200+ social groups, 8,500+ user strain reviews, over 3,900,000 strain page views, 2380 posted advice Q/A, 3700+ posted articles, and much more.

Buy PerkCoins

Featured marijuana stocks

Investorideas.com featured biotech and marijuana company - Scythian Biosciences Corp. (TSX.V: SCYB)

Scythian Biosciences Corp.

(TSX.V: SCYB)

Scythian Biosciences Corp. (TSX.V: SCYB) is a pre-clinical research and development company that is in the process of developing drug therapies. The first project underway is the development of a proprietary cannabinoid-based combination drug therapy for the treatment of concussions and traumatic brain injury. In addition to this primary line of research and development, Scythian also intends to develop other potential cannabinoid and non-cannabinoid based pharmaceutical products, including one that is in development for treatment of gastro-inflammatory disease.

Get News Alerts on Scythian Biosciences Corp.

Featured marijuana stocks

Investorideas.com featured marijuana company - SinglePoint, Inc. (OTC: SING)

SinglePoint, Inc.

(OTC: SING)

SinglePoint, Inc. (OTC: SING) has grown from a full-service mobile technology provider to a publicly traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base. Through its subsidiary company SingleSeed the company is providing products and services to the cannabis industry. www.SinglePoint.com

Get News Alerts on SinglePoint, Inc.

Investorideas.com at #CSE's 'Cannabis in the Capital Markets' in Kelowna

Interview with Timothy Taggart, CEO of American Growth Fund Series Two (AMREX), currently the only Cannabis Mutual Fund in the US

Marijuana News

ParcelPal (OTC: $PTNYF) (CSE: $PKG.CN) (FSE: $PT0) Begins Cannabis on Demand Delivery
Vancouver, British Columbia - November 22, 2017 (Investorideas.com Newswire) ParcelPal Technology Inc. (OTC: PTNYF) (CSE: PKG.CN) (FSE:PT0) ("ParcelPal" or the "Company) the Vancouver based on demand delivery company is pleased to announce they have successfully tested and have begun facilitating the delivery of medical cannabis to patients across Vancouver through a strategic partnership with the premium online dispensary, Birch + Fog

Breaking #Cannabis #ICO news: CannaSOS PerksCoin ICO is LIVE! 250,000 PCT Sold! Just 50,000 PerksCoins Remaining!
November 21, 2017 (Investorideas.com Newswire) Greetings CannaSOS Community! We have had quite the wild ride this past week with so many steps in the right direction for our ICO to be a super successful one, and we are stoked to share them with you.

CSE New Listing - Choom Holdings Inc. (CHOO); @CSE_News
November 21, 2017 (Investorideas.com Newswire) The common shares of Choom Holdings Inc. have been approved for listing on the CSE.

The Path to New Drug Discoveries and Development with #Cannabis
Point Roberts, WA - November 21, 2017 (Investorideas.com Newswire) Investorideas.com, a global news source and investor resource covering cannabis and hemp stocks issues a sector news alert on companies with new drug discoveries and developments in the sector.

#Cannabis Stock News; Veritas' (CSE: $VRT.C) (OTC: $VRTHF) Research Division to Begin Human Trials of Its Lead #Cannabis Strain for Pain; @VeritasPharma
Vancouver, B.C. - November 21, 2017 (Investorideas.com Newswire) Veritas Pharma Inc.- Cannabis and Biopharma News alert - (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), ("Veritas" or the "Company") reports that its research arm, Cannevert Therapeutics Ltd. ("CTL") has signed a letter of intent with the Fundación de Investigación (FDI) in San Juan, Puerto Rico, to conduct the first human study of CTL-X, its lead cannabis strain targeting pain.

New Brunswick becomes first province in Canada to fully secure safe supply of cannabis for all its consumers
ATHOLVILLE, NEW BRUNSWICK - November 20, 2017 (Investorideas.com Newswire) In the largest deal of its kind, the government of New Brunswick today announced a Memorandum of Understanding (MOU) with Zenabis for the safe and secure supply of cannabis and cannabis derivatives for the province's recreational marijuana users.

The Lowdown on Getting High in Canada
November 20, 2017 (Investorideas.com Newswire) Some 600 tonnes of marijuana a year are up for grabs as Canada moves to legalize weed, says Rick Mills, founder of Ahead of the Herd, who puts forth his case on why cannabis stocks should be in every investor's portfolio.

AgriTech Company Sells to Organic and Cannabis Markets
November 20, 2017 (Investorideas.com Newswire) The company's soon-to-be-announced prefeasibility study will evaluate expansion plans.

Veritas' (CSE: $VRT.C) (OTC: $VRTHF) Research Arm Cannevert Therapeutics Signs LOI with Fundación de Investigación of Puerto Rico to Begin Human Trials of Its Lead #Cannabis Strain for Pain
Vancouver, B.C. - November 20, 2017 (Investorideas.com Newswire) Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), ("Veritas" or the "Company") announces that its research arm, Cannevert Therapeutics Ltd. ("CTL") has signed a letter of intent with the Fundación de Investigación (FDI) in San Juan, Puerto Rico, to conduct the first human study of CTL-X, its lead cannabis strain targeting pain.

ParcelPal (OTC: $PTNYF) (CSE: $PKG.CN) (FSE: $PT0) Expands Restaurant Offerings on Platform
Vancouver, British Columbia - November 17, 2017 (Investorideas.com Newswire) ParcelPal Technology Inc. (OTC: PTNYF) (CSE: PKG.CN) (FSE:PT0) ("ParcelPal" or the "Company) the Vancouver based on demand delivery company is pleased to announce they have further expanded the amount of restaurant offerings in downtown Vancouver by adding another 50 restaurants to their platform.

Subscribe to Marijuana News RSS

Submit Articles Search More Articles

Sponsored Content


Cannabis Law News | Cannabis Law Report

New Frontier Cannabis News

The Cannabis Industry Annual Report

Indispensable to Sophisticated Investors

Invaluable to Successful Operators


Expert Corner Alan Brochstein, CFA - Cannabis Investor and Expert Alan Brochstein, CFA, Talks about the Evolution of the Sector; the Risks and Opportunities

Michael Swartz

"I believe that there was a landmark revelation in Spicer's comments that people may be overlooking" - Alan Brochstein, CFA

Point Roberts, WA, Delta BC – March 6­, 2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors including cannabis and hemp stocks features an exclusive interview with Alan Brochstein, CFA. Alan is a well-known expert in the sector and founded 420 Investor, a subscription-based due diligence platform for investors interested in publicly-traded cannabis stocks.

Alan talks about the evolution of the sector and some of the short and long term risks and opportunities.

Read complete interview

Expert Corner Michael J. Swartz, Analyst Viridian Capital & Research, LLC

Michael Swartz

Mr. Swartz serves as Senior Analyst at Viridian Capital & Research, where he leads all modeling and valuation work for the firm's M&A and fund raising assignments. He served as co-portfolio manager for the Osprey Financial Group, where he analyzed publicly traded companies with market capitalizations from $50 million to $1 billion and prepared buy-side equity reports containing buy-recommendations and original valuations derived from fundamental & technical analysis. In addition, Mr. Swartz served as the fund's Asian Economist, analyzing economic and geopolitical factors and assessing the Asia-Pacific region for attractive investment opportunities. Previously, Mr. Swartz worked as an Analyst at TBG Holdings, assisting clients with researching strategic options as it relates to market opportunities, competitive positioning, and allocation of resources. Mr. Swartz holds a B.B.A. in Finance and minor in Criminal Justice from the University of North Florida.

CANNABIS STOCKS: 2014 REVIEW AND 2015 OUTLOOK

Viridian Cannabis Index Gains 38.4% for 2014
Cannabis Stocks Will Attract More Institutional Funding in '15 and M&A Activity Will Rise
More Companies Will Fail as Shake Out Continues

More institutional capital will flow into public cannabis companies in 2015, reflecting the sector's growth prospects, but some individual companies will falter as investors and regulators demand performance. The backdrop and general momentum of the cannabis sector is positive as the reality of its national growth potential becomes more and more apparent, but the shake out of individual players that began last year will continue in 2015, as hype will not be enough to sustain companies in the eyes of investors, and may contribute to action by regulators. We will likely see a number of public cannabis companies fail this year. With increasing flows of ‘smart money' will come increasing demand for companies to demonstrate top-tier management and sustainable business models.

Report in pdf

Marijuana / Hemp Stock Directory Preview

22nd Century Group Inc. (NYSE MKT:XXII) is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants through genetic engineering and plant breeding. The Company's primary mission is to reduce the harm caused by smoking. 22nd Century currently owns or exclusively controls more than 200 issued patents and more than 50 pending patent applications around the world. The Company's strong IP position led to a licensing agreement with British American Tobacco ("BAT"), the world's second largest tobacco company.

3DX Industries Inc. (OTC: DDDX) is focused on the additive metal manufacturing segment within the manufacturing industry. 3DX has the capability of manufacturing a wide variety of products using its 3D metal printing system, 3D composite printing as well as more traditional methods of precision manufacturing. 3DX offers additive and subtractive manufacturing options as well as product design, engineering and assembly services to its customers. Cannabis: Has completed the development and design of a new and innovative product used for recovering excess heat from high energy grow lights. The part was designed specifically for the legalized cannabis markets including medical marijuana using the company's 3D Metal printing -- Binder Additive manufacturing process and is expected to be installed in select licensed facilities for real world testing in the coming months.

ABATTIS BIOCEUTICALS (OTC:ATTBF) is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The Company is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions, by supplying and partnering with companies to employ its mass cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. The Company also has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions.

Acology Inc (OTC:ACOL) markets and sells the TSOS Container™ (The Science of Storage).This container is the first-ever FDA approved polypropylene air-tight, water-tight, smell-proof delivery and storage container with a built-in grinder. It is manufactured from medical-grade No. 5 polypropylene resin, which is non-porous and non-leaching. These containers are portable and affordable. he Medtainer™ allows patients to store, grind and pour a variety of medications, including pills and all sizes and solidity, herbal medications and teas and even coffee and spices! The Medtainer™ can be ordered in with a certified child-resistant cap. Each Medtainer™ is water-proof and smell proof. Caregivers who are responsible for ensuring their patients medication regimens are universally pleased with the how easy and effective the Medtainer™ grind medications. It is an excellent solution for patients with dysphasia due to cognitive disorders or brain injuries, are in hospice or palliative situations and for anyone who would rather not swallow whole pills. The MedTainer™ was originally developed for geriatric and pediatric patients who had difficulty swallowing pills or needed an effective alternative to costly name-brand medications. The MedTainer™ has been sold and is being successfully used throughout the United States, Canada, Mexico and South America and Europe. Our association with the Medical Marijuana community was an unexpected windfall that has given Acology, Inc. the necessary funding to expand into the growing hospice and palliative care markets, and to help countless patients who are living at home or in small home-like settings and need help swallowing pills.

Advantis Corp (OTC:ADVT) develops products and works with developing companies to provide innovative healthcare products, holistic pain management solutions, and enhance the footprint in the evolving legal cannabis business. Advantis acquires ownership in developing companies that work within the nutraceutical and the alternative health care industries; consulting with these organizations to improve their product lines, expand their distribution channels through internal partnership agreements, and heighten brand value.

AeroGrow International, Inc. (OTC:AERO) Headquartered in Boulder, Colorado, AeroGrow International, Inc. is the leader in the rapidly growing indoor gardening category. AeroGardens allow anyone to grow farmer's market fresh herbs, salad greens, tomatoes, chili peppers, flowers and more, indoors, year-round, so simply and easily that no green thumb is required. With an AeroGarden... you can grow anything! In April 2013, AeroGrow entered into a strategic partnership with Scotts Miracle-Gro to continue to expand the indoor gardening market.

AFFINOR GROWERS (CSE:AFI; OTC:RSSFF) is focused on growing high quality crops such as romaine lettuce, spinach, strawberries and high quality medical Marijuana. Affinor is committed to becoming a pre-eminent grower, using exclusive vertical farming techniques.

Agritek Holdings Inc (OTC:AGTK) a fully reporting Company and pioneer within the medicinal marijuana space provides innovative patient and agricultural solutions seeks to be the leader in Compassionate Care Technology for the medicinal marijuana industry. Agritek Holdings provides real estate management and health and wellness product lines through its wholly-owned subsidiary, Agritek Holdings Inc. Agritek Holdings Inc. does not directly grow, harvest, or distribute or sell cannabis or any substances that violate United States law or the Controlled Substances Act, nor does it intend to do so in the future.

ALGAE DYNAMICS CORP (OTCQB: ADYNF) is currently engaged in the commercialization of our proprietary BioSilo® algae cultivation system for the high volume, low cost production of pure contaminant-free algae biomass. This biomass is high in Omega-3s DHA/DPA, vitamins, minerals and antioxidants, all of which are in demand by the growing multibillion dollar food/beverage and health care sectors. Our integrated BioSilo® manufacturing system provides low cost algae biomass production with modest capital cost requirements compared to conventional approaches. Furthermore, our "controlled outcomes" technology provides ultra-high purity algae biomass, differentiating it from other producers in the market. Following completion of a commercial-scale production facility we intend to produce algae biomass for sale into the functional additive and supplement markets, focusing on Chlorella and Omega-3 oil.

Alliance Growers Corp. (CSE:ACG) is a cannabis company dedicated to building shareholder value through its 4 Pillars business strategy. The company was incorporated in 2014 and is publicly traded on the CSE under the symbol ACG. The company's head office is in Vancouver, BC and its interest in a marijuana production facility in Kelowna, BC.

See the full stock directory here

Investor Resources